Casi pharmaceuticals provides business and clinical update

Beijing, china / access newswire / may 19, 2025 / casi pharmaceuticals, inc. (nasdaq:casi), ("casi" or the "company"), a cayman incorporated biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, announced that it will host a live conference call and webcast at 8:00 a.m. pt/11:00 a.m.
CASI Ratings Summary
CASI Quant Ranking